NOVONIX Ltd
NVXdata completeness 100%6 fiscal years on fileData notes: no data for concept 'interestExpense'
NOVONIX Ltd earns about -31% on invested capital, but has diluted owners by 129% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $3.89M1 | $6.1M1 | $8.05M1 | $5.85M2 | $5.62M2 |
| Net income | −$13.4M3 | −$51.9M4 | −$46.2M5 | −$74.8M5 | −$92.7M5 |
| Operating cash flow | −$6.09M6 | −$29.2M7 | −$36.2M8 | −$40.4M8 | −$42.2M8 |
| Capital expenditure | $19.5M9 | $83.7M10 | $19.2M11 | $29.9M11 | $60.2M11 |
| Free cash flow (derived) | −$25.6M6 | −$112.9M7 | −$55.4M8 | −$70.3M8 | −$102.4M8 |
| Total debt | $4.7M12 | $37M12 | $64.6M13 | $64.4M14 | $93.8M14 |
| Cash & equivalents | $102.6M15 | $142.7M15 | $78.7M16 | $42.6M16 | $79.9M16 |
| Diluted shares | 366.3M | 486.0M | 488.7M | 488.7M | 840.1M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $1.92 of net worth that earned you −$1.1 and generated −$1.22 of cash last year, against $1.12 of debt.
It earned an average -31% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 129% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has risen 1896% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 20-F · period ending 2021-06-30 · accession 0000950170-24-021622 (Revenue)
- 20-F · period ending 2024-12-31 · accession 0001193125-26-072814 (RevenueFromContractsWithCustomers)
- 20-F · period ending 2021-06-30 · accession 0000950170-24-021622 (ProfitLoss)
- 20-F · period ending 2022-06-30 · accession 0000950170-25-029488 (ProfitLoss)
- 20-F · period ending 2023-12-31 · accession 0001193125-26-072814 (ProfitLoss)
- 20-F · period ending 2021-06-30 · accession 0000950170-24-021622 (CashFlowsFromUsedInOperatingActivities)
- 20-F · period ending 2022-06-30 · accession 0000950170-25-029488 (CashFlowsFromUsedInOperatingActivities)
- 20-F · period ending 2023-12-31 · accession 0001193125-26-072814 (CashFlowsFromUsedInOperatingActivities)
- 20-F · period ending 2021-06-30 · accession 0000950170-24-021622 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 20-F · period ending 2022-06-30 · accession 0000950170-25-029488 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 20-F · period ending 2023-12-31 · accession 0001193125-26-072814 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 20-F · period ending 2021-06-30 · accession 0000950170-23-004852 (Borrowings)
- 20-F · period ending 2023-12-31 · accession 0000950170-25-029488 (Borrowings)
- 20-F · period ending 2024-12-31 · accession 0001193125-26-072814 (Borrowings)
- 20-F · period ending 2021-06-30 · accession 0000950170-25-029488 (CashAndCashEquivalents)
- 20-F · period ending 2023-12-31 · accession 0001193125-26-072814 (CashAndCashEquivalents)